Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Primary Generalized Tonic-Clonic Seizures
NCT00236418Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 1994
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate, sponsored by Johnson & Johnson. Started Dec 1994; status: completed.
02
Drugs
topiramate
Beyond the preview
Go deeper on NCT00236418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236418.